Lipocine is trading 5% down at $1.52 as broader markets weaken.
- Provided market context reports significant declines in the Nasdaq and S&P 500 amid concerns about AI spending and geopolitical tensions affecting oil markets.
- No Lipocine announcement for October 22, 2026, was found in company press-release listings; the latest listed release is dated October 7.
- Intraday volume was not verified.